Efficacy of tiotropium and indacaterol monotherapy and their combination on dynamic lung hyperinflation in COPD: A random open-label crossover study
International Journal of COPD Nov 09, 2017
Fujimoto K, et al. - The difference in efficacy of long-acting muscarinic antagonist (LAMA) and long-acting β2-agonists (LABAs) alone and the combination thereof for dynamic lung hyperinflation (DLH) were explained in this random open-label crossover study. Following metronome-paced incremental hyperventilation, the efficacy of tiotropium in inhibiting DLH could be superior to that of 150 μg indacaterol, even though the effects on airflow obstruction were the same. The combination therapy demonstrated further improvement in airflow obstruction, but not in DLH.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries